Trials / Completed
CompletedNCT00865670
To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions
Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Geneva 600 mg Azithromycin Monohydrate Tablets and Pfizer Inc. (Zithromax) 600 mg Azithromycin Dihydrate Tablets in Healthy Adult Volunteers Under Fed Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the bioequivalence of Azithromycin 600 mg Tablets Under Fed Conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin Monohydrate 600 mg Tablets | |
| DRUG | Zithromax (azithromycin dihydrate) 600 mg Tablets |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2003-09-01
- Completion
- 2003-09-01
- First posted
- 2009-03-19
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00865670. Inclusion in this directory is not an endorsement.